We now have two new COVID-19 vaccines available for this year’s respiratory virus season, one from Pfizer and one from Moderna, which are expected to perform well against current variants. The FDA approved both vaccines this week, and the CDC recommended them for almost all Americans. A third option, from Novavax, may become available in the coming weeks as well.
Read More
For the second week in a row, available data suggest that the current COVID-19 surge may be turning around, or at least heading for a plateau. But there’s still a lot of coronavirus going around—and this will likely remain true through the winter respiratory virus season.
Read More
Over the last few weeks, the signals of a summer COVID-19 surge in the U.S. have grown steadily clearer. Viral levels in wastewater, test positivity, and hospitalizations are all climbing across the country.
Read More
COVID-19 data in the U.S. is showing increasingly clear signs of a summer surge, with infections rising across the country. However, thanks to the federal public health emergency’s end, we have less and less data to track this trend.
Read More
National COVID-19 data are showing signs of a summer uptick in infections across multiple regions. Newer variants, summer travel, and holidays are likely contributing to this increase, though it’s hard to say if we will see a real surge or a continued shifting of the U.S.’s high COVID-19 baseline.
Read More
Nationally, the COVID-19 situation in the U.S. is similar to where we’ve been for the last few weeks. Major metrics (such as we have them) show an overall plateau in disease spread. Wastewater trends in a few places suggest a summer surge might be coming, but it’s hard to say for sure.
Read More
The COVID-19 plateau continues, with hospital admissions and viral levels in wastewater (the two main metrics I’m looking at these days) both trending slightly down at the national level. Newer Omicron variants are still on the rise, but don’t seem to be impacting transmission much yet.
Read More
COVID-19 spread continues to trend down in the U.S., though our data for tracking this disease is now worse than ever thanks to the end of the federal public health emergency. If newer Omicron variants cause a surge this summer, those increases will be hard to spot.
Read More
The national COVID-19 plateau persists. Cases, new hospitalizations, and wastewater surveillance all indicate slight declines (but persistent disease spread) across the country. New variants are on the rise, but have yet to noticeably change these trends.
Read More
Major COVID-19 metrics continue to suggest an ongoing (though slight) decline in the virus’ spread nationally, despite the rise of newer and more contagious variants. The moderate plateau persists.
Read More